Cargando…

Essential m(6)A Methylation Regulator HNRNPC Serves as a Targetable Biomarker for Papillary Renal Cell Carcinoma

m(6)A RNA modification is a common abundant posttranscriptional modification of mRNAs occurring in cancer growth and progression. Accumulated evidence has proved that HNRNPC, which acts as a m(6)A reader, plays an essential role in the promotion of cancer occurrence and development; nevertheless, th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Jiajin, Wei, Yuang, Miao, Chenkui, Wang, Songbo, Wang, Xiaoyi, Wang, Zengjun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9056237/ https://www.ncbi.nlm.nih.gov/pubmed/35502201 http://dx.doi.org/10.1155/2022/9411692

Ejemplares similares

SPTBN1 abrogates renal clear cell carcinoma progression via glycolysis reprogramming in a GPT2-dependent manner
por: Wu, Jiajin, et al.
Publicado: (2022)

Integrated single-cell and bulk characterization of cuproptosis key regulator PDHB and association with tumor microenvironment infiltration in clear cell renal cell carcinoma
por: Wu, Jiajin, et al.
Publicado: (2023)

M6A RNA Methylation Regulator HNRNPC Contributes to Tumorigenesis and Predicts Prognosis in Glioblastoma Multiforme
por: Wang, Li-chong, et al.
Publicado: (2020)

Apolipoprotein C1 (APOC1): A Novel Diagnostic and Prognostic Biomarker for Clear Cell Renal Cell Carcinoma
por: Cui, Yankang, et al.
Publicado: (2020)

Comprehensive Analysis of m(5)C RNA Methylation Regulator Genes in Clear Cell Renal Cell Carcinoma
por: Wu, Jiajin, et al.
Publicado: (2021)

High expression of CDCA7 predicts poor prognosis for clear cell renal cell carcinoma and explores its associations with immunity
por: Liu, Shouyong, et al.
Publicado: (2021)

Effects of VEGF and VEGFR polymorphisms on the outcome of patients with metastatic renal cell carcinoma treated with sunitinib: a systematic review and meta-analysis
por: Miao, Chenkui, et al.
Publicado: (2017)

Identification and Validation of Three m6A Regulators: FTO, HNRNPC, and HNRNPA2B1 as Potential Biomarkers for Endometriosis
por: Sun, Jiani, et al.
Publicado: (2022)

Comprehensive managements of metastatic renal tumor with Mayo III inferior vena cava tumor thrombus: a case report
por: Miao, Chenkui, et al.
Publicado: (2020)

HNRNPC Promotes Proliferation, Metastasis and Predicts Prognosis in Prostate Cancer
por: Wang, Shiyu, et al.
Publicado: (2021)

M6A-related bioinformatics analysis reveals that HNRNPC facilitates progression of OSCC via EMT
por: Huang, Guang-Zhao, et al.
Publicado: (2020)

hnRNPC regulates cancer-specific alternative cleavage and polyadenylation profiles
por: Fischl, Harry, et al.
Publicado: (2019)

Silencing CAPN2 Expression Inhibited Castration-Resistant Prostate Cancer Cells Proliferation and Invasion via AKT/mTOR Signal Pathway
por: Li, Pu, et al.
Publicado: (2017)

Emerging Roles of Circ-ZNF609 in Multiple Human Diseases
por: Wang, Songbo, et al.
Publicado: (2022)

hnRNPC Promotes Malignancy in Pancreatic Cancer through Stabilization of IQGAP3
por: Yang, Nannan, et al.
Publicado: (2022)

Protective Effects of the Segmental Renal Artery Clamping Technique on Ischemia-Reperfusion Injury in db/db Diabetic Mice
por: Liang, Chao, et al.
Publicado: (2017)

SKA3 Serves as a Biomarker for Poor Prognosis in Kidney Renal Papillary Cell Carcinoma
por: Feng, Dechao, et al.
Publicado: (2021)

Renal Ewing sarcoma/primitive neuroectodermal tumor in a pregnant woman who underwent robot-assisted laparoscopic nephrectomy: a case report and literature review
por: Miao, Chenkui, et al.
Publicado: (2018)

USP39 promotes hepatocellular carcinogenesis through regulating alternative splicing in cooperation with SRSF6/HNRNPC
por: Zheng, Jingyi, et al.
Publicado: (2023)

Identification of prognostic biomarkers in papillary renal cell carcinoma and PTTG1 may serve as a biomarker for predicting immunotherapy response
por: Tian, Xi, et al.
Publicado: (2022)

Influence of N6-Methyladenosine Modification Gene HNRNPC on Cell Phenotype in Parkinson's Disease
por: Quan, Wei, et al.
Publicado: (2021)

AB034. Advances in the diagnosis and treatment of ejaculatory duct obstructive diseases
por: Wang, Zengjun, et al.
Publicado: (2018)

Effect of Enhanced Recovery After Surgery on Postoperative Recovery and Quality of Life in Patients Undergoing Laparoscopic Partial Nephrectomy
por: Miao, Chenkui, et al.
Publicado: (2020)

Function of HNRNPC in breast cancer cells by controlling the dsRNA‐induced interferon response
por: Wu, Yusheng, et al.
Publicado: (2018)

Application and analysis of retroperitoneal laparoscopic partial nephrectomy with sequential segmental renal artery clamping for patients with multiple renal tumor: initial experience
por: Zhu, Jundong, et al.
Publicado: (2017)

Overexpression of hnRNPC2 induces multinucleation by repression of Aurora B in hepatocellular carcinoma cells
por: SUN, DA-QUAN, et al.
Publicado: (2013)

lncRNA MIR4435‐2HG promoted clear cell renal cell carcinoma malignant progression via miR‐513a‐5p/KLF6 axis
por: Zhu, Kai, et al.
Publicado: (2020)

HNRNPC downregulation inhibits IL‐6/STAT3‐mediated HCC metastasis by decreasing HIF1A expression
por: Liu, Danfei, et al.
Publicado: (2022)

Overexpression of CAPN2 promotes cell metastasis and proliferation via AKT/mTOR signaling in renal cell carcinoma
por: Miao, Chenkui, et al.
Publicado: (2017)

Case report: Identification of a novel HNRNPC::RARG fusion in acute promyelocytic leukemia lacking RARA rearrangement
por: Ding, Wenjing, et al.
Publicado: (2023)

Analysis and validation of m6A regulatory network: a novel circBACH2/has-miR-944/HNRNPC axis in breast cancer progression
por: Lv, Wenchang, et al.
Publicado: (2021)

CD151 promotes cell metastasis via activating TGF-β1/Smad signaling in renal cell carcinoma
por: Yu, Yajie, et al.
Publicado: (2018)

m(6)A RNA Methylation Regulators Impact Prognosis and Tumor Microenvironment in Renal Papillary Cell Carcinoma
por: Chen, Lianze, et al.
Publicado: (2021)

HNRNPC, a predictor of prognosis and immunotherapy response based on bioinformatics analysis, is related to proliferation and invasion of NSCLC cells
por: Gu, Zhuoyu, et al.
Publicado: (2022)

HNRNPC suppresses tumor immune microenvironment by activating Treg cells promoting the progression of prostate cancer
por: Cheng, Yifei, et al.
Publicado: (2023)

Circular RNA circ‐FIRRE interacts with HNRNPC to promote esophageal squamous cell carcinoma progression by stabilizing GLI2 mRNA
por: Zhou, Yongjia, et al.
Publicado: (2023)

TRIM29 as a prognostic predictor for multiple human malignant neoplasms: a systematic review and meta-analysis
por: Liang, Chao, et al.
Publicado: (2017)

Treatment of Mullerian duct cyst by combination of transurethral resection and seminal vesiculoscopy: An initial experience
por: Miao, Chenkui, et al.
Publicado: (2019)

Clusterin suppresses invasion and metastasis of testicular seminoma by upregulating COL15a1
por: Cui, Yankang, et al.
Publicado: (2021)

Identification of autophagy-related long non-coding RNA prognostic and immune signature for clear cell renal cell carcinoma
por: Cui, Yankang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gve2av71hqiir1jnnup8tu5o8m